...
首页> 外文期刊>European Journal of Radiology Open >Comparison of organ-specific-radiation dose levels between 70kVp perfusion CT and standard tri-phasic liver CT in patients with hepatocellular carcinoma using a Monte-Carlo-Simulation-based analysis platform
【24h】

Comparison of organ-specific-radiation dose levels between 70kVp perfusion CT and standard tri-phasic liver CT in patients with hepatocellular carcinoma using a Monte-Carlo-Simulation-based analysis platform

机译:使用基于蒙特卡洛模拟的分析平台比较肝癌患者70 kVp灌注CT与标准三相肝CT之间的器官特异性放射剂量水平

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose The aim of this study was to systematically compare organ-specific-radiation dose levels between a radiation dose optimized perfusion CT (dVPCT) protocol of the liver and a tri-phasic standard CT protocol of the liver using a Monte-Carlo-Simulation-based analysis platform. Methods and materials The complete CT data of 52 patients (41 males; mean age 65 ± 12) with suspected HCC that underwent dVPCT examinations on a 3rd generation dual-source CT (Somatom Force, Siemens) with a dose optimized tube voltage of 70 kVp or 80 kVp were exported to an analysis platform (Radimetrics, Bayer). The dVPCT studies were matched with a reference group of 50 patients (35 males; mean age 65 ± 14) that underwent standard tri-phasic CT (sCT) examinations of the liver with 130 kVp using the calculated water-equivalent-diameter of the patients. The analysis platform was used for the calculation of the organ-specific effective dose (ED) as well as global radiation-dose parameters (ICRP103). Results The organ-specific ED of the dVPCT protocol was statistically significantly lower when compared to the sCT in 14 of 21, and noninferior in a total of 18 of 21 examined items (all p 0.05). The EDs of the dVPCT examinations were especially in the dose sensitive organs such as the red marrow (17.3 mSv vs 24.6 mSv, p = 0.0001) and the liver (33.3 mSv vs 46.9 mSv, p = 0.0003) lower when compared to the sCT. Conclusion Our results suggest that dVPCT performed at 70 or 80 kVp compares favorably to sCT performed with 130 kVp with regard to effective organ dose levels, especially in dose sensitive organs, while providing additional functional information which is of paramount importance in patients undergoing novel targeted therapies.
机译:目的这项研究的目的是使用Monte-Carlo-Simulation-系统地比较肝脏的放射剂量优化灌注CT(dVPCT)方案和肝脏的三相标准CT方案之间的器官特异性放射剂量水平。基于分析的平台。方法和材料对52例疑似HCC患者(41例男性,平均年龄65±12)的完整CT数据进行了第三代双源CT(Somatom Force,西门子)的dVPCT检查,剂量优化管电压为70 kVp或80 kVp出口到分析平台(Radimetrics,Bayer)。 dVPCT研究与参考患者50例(男性35例;平均年龄65±14)进行了匹配,他们使用计算出的患者水当量直径对130 kVp的肝脏进行了标准的三相CT(sCT)检查。该分析平台用于计算器官特异性有效剂量(ED)以及总体辐射剂量参数(ICRP103)。结果与sCT相比,dVPCT方案的器官特异性ED在21个检查项中有14个在统计学上显着降低,在21个检查项目中有18个均不低于sCT(所有p <0.05)。与sCT相比,dVPCT检查的ED尤其在剂量敏感器官中,例如红骨髓(17.3 mSv vs 24.6 mSv,p = 0.0001)和肝脏(33.3 mSv vs 46.9 mSv,p = 0.0003)低。 。结论我们的结果表明,在有效器官剂量水平,特别是在剂量敏感器官中,以70 kVp或80 kVp进行的dVPCT优于以130 kVp进行的sCT,同时提供了其他功能信息,这对于接受新型靶向治疗的患者至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号